X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (2301) 2301
Newspaper Article (849) 849
Publication (265) 265
Patent (224) 224
Book Review (211) 211
Conference Proceeding (148) 148
Magazine Article (115) 115
Book / eBook (62) 62
Book Chapter (54) 54
Dissertation (54) 54
Web Resource (38) 38
Reference (8) 8
Report (3) 3
Trade Publication Article (2) 2
Video Recording (2) 2
Government Document (1) 1
Journal / eJournal (1) 1
Newsletter (1) 1
Technical Report (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
index medicus (1145) 1145
humans (1028) 1028
cardiac & cardiovascular systems (771) 771
heart failure (711) 711
male (662) 662
female (658) 658
aged (504) 504
mortality (454) 454
middle aged (449) 449
abridged index medicus (368) 368
heart failure - drug therapy (295) 295
prognosis (253) 253
risk factors (250) 250
cardiovascular (200) 200
treatment outcome (189) 189
heart failure - mortality (185) 185
heart failure - physiopathology (185) 185
medicine, general & internal (167) 167
double-blind method (163) 163
heart attacks (159) 159
drug therapy (153) 153
adult (149) 149
morbidity (148) 148
hospitalization (145) 145
care and treatment (142) 142
clinical trials (137) 137
tetrazoles - therapeutic use (135) 135
analysis (133) 133
peripheral vascular disease (129) 129
outcomes (126) 126
angiotensin-converting enzyme inhibitors - therapeutic use (121) 121
research (121) 121
cardiac patients (120) 120
cardiovascular disease (120) 120
diabetes (118) 118
survival (118) 118
internal medicine (117) 117
trial (117) 117
risk (116) 116
aged, 80 and over (115) 115
animals (114) 114
follow-up studies (114) 114
cardiac and cardiovascular systems (113) 113
kardiologi (113) 113
randomized controlled trials as topic (99) 99
left-ventricular dysfunction (96) 96
valsartan (95) 95
cardiology (94) 94
myocardial infarction (92) 92
heart failure - diagnosis (91) 91
management (91) 91
myocardial-infarction (90) 90
article (88) 88
patients (86) 86
proportional hazards models (85) 85
clinical medicine (84) 84
heart failure - epidemiology (84) 84
physics (83) 83
stroke volume (83) 83
disease (82) 82
prevalence (81) 81
chronic disease (79) 79
heart failure - complications (79) 79
angiotensin ii type 1 receptor blockers - therapeutic use (78) 78
patient outcomes (78) 78
time factors (78) 78
atrial fibrillation (77) 77
enalapril (77) 77
heart (76) 76
heart diseases (76) 76
cardiovascular diseases (75) 75
stroke (75) 75
studies (75) 75
angiotensin (74) 74
diagnosis (74) 74
hospitalization - statistics & numerical data (74) 74
hypertension (74) 74
epidemiology (72) 72
heart failure - therapy (72) 72
risk assessment (72) 72
acute myocardial-infarction (71) 71
candesartan (71) 71
prospective studies (71) 71
heart-failure (70) 70
klinisk medicin (69) 69
health aspects (68) 68
stroke volume - physiology (68) 68
heart attack (65) 65
calculating (63) 63
computing (63) 63
counting (63) 63
ejection fraction (62) 62
heart failure - blood (61) 61
blood pressure (60) 60
dysfunction (60) 60
biochemistry & molecular biology (59) 59
myocardial infarction - complications (59) 59
dose-response relationship, drug (58) 58
incidence (58) 58
cardiology and cardiovascular medicine (57) 57
more...
Library Location Library Location
Library Location Library Location
X
Sort by Item Count (A-Z)
Filter by Count
Robarts - Stacks (17) 17
UTL at Downsview - May be requested (16) 16
Online Resources - Online (12) 12
Gerstein Science - Stacks (9) 9
UofT at Scarborough - Stacks (8) 8
UofT at Mississauga - Stacks (7) 7
Collection Dvlpm't (Acquisitions) - Vendor file (4) 4
OISE - Stacks (4) 4
St. Michael's College (John M. Kelly) - 2nd Floor (3) 3
Architecture Landscape (Shore + Moffat) - Stacks (2) 2
Collection Dvlpm't (Acquisitions) - Closed Orders (2) 2
St. Augustine's Seminary - Stacks (2) 2
Victoria University E.J. Pratt - Stacks (2) 2
Architecture Landscape (Shore + Moffat) - Protected Material (1) 1
Chemistry (A D Allen) - Stacks (1) 1
Engineering & Comp. Sci. - Missing (1) 1
Gerstein Science - Reference (1) 1
Knox College (Caven) - Storage (1) 1
Law (Bora Laskin) - Stacks (1) 1
Media Commons - Audio Visual (1) 1
Music - Stacks (1) 1
OISE - Microfiche (1) 1
OISE - Storage (1) 1
Pontifical Inst. Mediaeval Studies - Library use only (1) 1
Royal Ontario Museum - Stacks (1) 1
St. Michael's College (John M. Kelly) - Circulation Desk (1) 1
Thomas Fisher Rare Book - Rare Book (1) 1
Trinity College (John W Graham) - Stacks (1) 1
Trinity College (John W Graham) - Storage (1) 1
University Archives - Archives (1) 1
UofT at Mississauga - Reference (1) 1
UofT at Scarborough - May be requested in 6-10 wks (1) 1
Victoria University E.J. Pratt - Storage (1) 1
Victoria University Emmanuel College - Oversize (1) 1
Victoria University Emmanuel College - Stacks (1) 1
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (3747) 3747
French (52) 52
German (44) 44
Spanish (24) 24
Chinese (7) 7
Portuguese (5) 5
Korean (3) 3
Norwegian (2) 2
Polish (2) 2
Turkish (2) 2
Croatian (1) 1
Hebrew (1) 1
Italian (1) 1
Japanese (1) 1
Slovak (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


by Hernandez, Adrian F and Green, Fiona and Green, Jennifer B and Janmohamed, Salim and D'Agostino, Ralph B and Granger, Christopher B and Jones, Michael and Jones, Nigel P and Leiter, Lawrence A and Rosenberg, Anne E and Rosenberg, Anne and Sigmon, Kristina and Sigmon, Kristina N and Somerville, Matthew and Somerville, Matthew C and Thorpe, Karl and Thorpe, Karl M and McMurray, John J V and McMurray, John J.V and Del Prato, Stefano and Califf, Robert M and Holman, Rury and DeMets, David and Riddle, Matthew and Goodman, Shaun and McGuire, Darren and Alexander, Karen and Devore, Adam and Melloni, Chiara and Patel, Chetan and Patel, Rajesh and Patel, Vickas and Patel, Prashant and Patel, Rajivkumar and Kong, David and Bloomfield, Gerald and Roe, Matthew and Tricoci, Pierluigi and Harrison, Rob and Harrison, Lindsay and Lopes, Renato and Mathews, Robin and Mehta, Anand and Mehta, Rajendra and Schuyler Jones, William and Vemulapalli, Sreekanth and Povsic, Thomas and Eapen, Zubin and Dombrowski, Keith and Kolls, Brad and Jordan, Dedrick and Ambrosy, Andrew and Greene, Deb and Greene, Stephen and Mandawat, Aditya and Shavadia, Jay and Cooper, John and Cooper, Lauren and Sharma, Abhinav and Sharma, Richa and Guimaraes, Patricia and Friedman, Daniel and Wilson, Matt and Wilson, Tim and Endsley, Patricia and Gentry, Tracy and Collier, Jeannie and Perez, Kathleen and James, Kourtnei and James, Rachel and Roush, Jennifer and Pope, Connie and Howell, Christina and Johnson, Megan and Johnson, David and Johnson, Andrew and Bailey, Matt and Cole, Joanna and Akers, Teresa and Vandyne, Beth and Thomas, Betsy and Rich, Jenny and Bartone, Susan and Beaulieu, Gail and Brown, Judith and Brown, Kim and Chau, Tuan and Christian, Tamra and Coker, Rebecca and Haddock, Trevorlyn and Jenkins, Wendy and Haque, Ghazala and Marquess, Marsha and Pesarchick, Jean and Rethaford, Renee and Stone, Allegra and Al Kawas, Firas and Anderson, Michelle and Enns, Robert and Sinay, Isaac and ... and Harmony Outcomes Comm Investigator and Harmony Outcomes committees and investigators
The Lancet, ISSN 0140-6736, 10/2018, Volume 392, Issue 10157, pp. 1519 - 1529
Glucagon-like peptide 1 receptor agonists differ in chemical structure, duration of action, and in their effects on clinical outcomes. The cardiovascular... 
MEDICINE, GENERAL & INTERNAL | RISK | METAANALYSIS | MELLITUS | SAFETY | RECEPTOR AGONISTS | Hypoglycemic Agents - therapeutic use | Cardiovascular Diseases - etiology | Stroke - prevention & control | Double-Blind Method | Drug Administration Schedule | Glucagon-Like Peptide 1 - administration & dosage | Glucagon-Like Peptide 1 - analogs & derivatives | Cardiovascular Diseases - prevention & control | Humans | Middle Aged | Kaplan-Meier Estimate | Male | Treatment Outcome | Stroke - etiology | Hypoglycemic Agents - administration & dosage | Injections, Subcutaneous | Adult | Female | Aged | Myocardial Infarction - prevention & control | Diabetes Mellitus, Type 2 - drug therapy | Myocardial Infarction - etiology | Diabetes Mellitus, Type 2 - complications | Glucagon-Like Peptide 1 - therapeutic use | Myocardial infarction | Diabetic retinopathy | Heart attacks | Peptides | Glucagon | Medical services | Clinical trials | Cardiovascular disease | Thyroid gland | Incidence | Thyroid carcinoma | Randomization | Motivation | Hemoglobin | Diuretics | Diabetes mellitus (non-insulin dependent) | Glucagon-like peptide 1 | Thyroid | Cerebral infarction | Stroke | Diabetes mellitus | Pancreatitis | Health risks | Risk reduction | Disease control | Patients | Organic chemistry | Interactive systems | Pancreatic cancer | Fatalities | Infarction | Diabetes | Cardiovascular diseases | Health risk assessment | Cancer | Index Medicus | Abridged Index Medicus
Journal Article
by Swerdlow, Daniel I, Dr and Preiss, David, Dr and Kuchenbaecker, Karoline B, MSc and Holmes, Michael V, PhD and Engmann, Jorgen E L, MSc and Shah, Tina, PhD and Sofat, Reecha, MD and Stender, Stefan, MD and Johnson, Paul C D, PhD and Scott, Robert A, PhD and Leusink, Maarten, MSc and Verweij, Niek, MD and Sharp, Stephen J, MSc and Guo, Yiran, PhD and Giambartolomei, Claudia, MSc and Chung, Christina, MSc and Peasey, Anne, PhD and Amuzu, Antoinette, MSc and Li, KaWah, MSc and Palmen, Jutta, MSc and Howard, Philip, MSc and Cooper, Jackie A, MSc and Drenos, Fotios, PhD and Li, Yun R, BSc and Lowe, Gordon, Prof and Gallacher, John, PhD and Stewart, Marlene C W, PhD and Tzoulaki, Ioanna, PhD and Buxbaum, Sarah G, PhD and van der A, Daphne L, PhD and Forouhi, Nita G, MRCP and Onland-Moret, N Charlotte, PhD and van der Schouw, Yvonne T, Prof and Schnabel, Renate B, MD and Hubacek, Jaroslav A, PhD and Kubinova, Ruzena, MD and Baceviciene, Migle, MD and Tamosiunas, Abdonas, Prof and Pajak, Andrzej, Prof and Topor-Madry, Romanvan, MD and Stepaniak, Urszula, PhD and Malyutina, Sofia, Prof and Baldassarre, Damiano, PhD and Sennblad, Bengt, PhD and Tremoli, Elena, Prof and de Faire, Ulf, Prof and Veglia, Fabrizio, PhD and Ford, Ian, Prof and Jukema, J Wouter, Prof and Westendorp, Rudi G J, Prof and de Borst, Gert Jan, MD and de Jong, Pim A, MD and Algra, Ale, Prof and Spiering, Wilko, MD and der Zee, Anke H Maitland-van, PhD and Klungel, Olaf H, PharmD and de Boer, Anthonius, Prof and Doevendans, Pieter A, Prof and Eaton, Charles B, Prof and Robinson, Jennifer G, Prof and Duggan, David, PhD and Kjekshus, John, Prof and Downs, John R, MD and Gotto, Antonio M, MD and Keech, Anthony C, MD and Marchioli, Roberto, MD and Tognoni, Gianni, MD and Sever, Peter S, Prof and Poulter, Neil R, Prof and Waters, David D, MD and Pedersen, Terje R, MD and Amarenco, Pierre, MD and Nakamura, Haruo, MD and McMurray, John J V, Prof and Lewsey, James D, PhD and Chasman, Daniel I, PhD and Ridker, Paul M, MD and Maggioni, Aldo P, Prof and Tavazzi, Luigi, Prof and Ray, Kausik K, Prof and Seshasai, Sreenivasa Rao Kondapally, MD and Manson, JoAnn E, Prof and Price, Jackie F, MD and Whincup, Peter H, Prof and Morris, Richard W, Prof and Lawlor, Debbie A, Prof and Smith, George Davey, Prof and Ben-Shlomo, Yoav, Prof and Schreiner, Pamela J, Prof and Fornage, Myriam, Prof and Siscovick, David S, Prof and Cushman, Mary, MD and Kumari, Meena, PhD and Wareham, Nick J, Prof and Verschuren, W M Monique, PhD and Redline, Susan, Prof and Patel, Sanjay R, MD and Whittaker, John C, Prof and Hamsten, Anders, Prof and Delaney, Joseph A, PhD and ... and MAGIC Consortium and InterAct Consortium and DIAGRAM Consortium
The Lancet, ISSN 0140-6736, 01/2015, Volume 385, Issue 9965, pp. 351 - 361
Journal Article
The New England Journal of Medicine, ISSN 0028-4793, 11/2007, Volume 357, Issue 22, pp. 2248 - 2261
In this clinical trial, rosuvastatin was compared with placebo in elderly patients with systolic, ischemic heart failure. Although rosuvastatin significantly... 
MORTALITY | SURVIVAL | MEDICINE, GENERAL & INTERNAL | DESIGN | THERAPY | EVENTS | MYOCARDIAL-INFARCTION | CHOLESTEROL | DISEASE | PRAVASTATIN | STATINS | Single-Blind Method | Follow-Up Studies | Humans | Middle Aged | Hospitalization - statistics & numerical data | Male | Systole | Cardiovascular Diseases - epidemiology | Cardiovascular Diseases - mortality | Female | Heart Failure - etiology | Proportional Hazards Models | Rosuvastatin Calcium | Treatment Outcome | Heart Failure - drug therapy | Hydroxymethylglutaryl-CoA Reductase Inhibitors - adverse effects | Sulfonamides - therapeutic use | Pyrimidines - therapeutic use | Hydroxymethylglutaryl-CoA Reductase Inhibitors - therapeutic use | Myocardial Ischemia - complications | Pyrimidines - adverse effects | Sulfonamides - adverse effects | Aged | Fluorobenzenes - adverse effects | Fluorobenzenes - therapeutic use | Heart failure | Placebos | Rosuvastatin | Dosage and administration | Drug therapy | Comparative analysis | Cardiovascular disease | Heart attacks | Index Medicus | Abridged Index Medicus | Cardiovascular Diseases | MEDICIN OCH HÄLSOVETENSKAP | Myocardial Ischemia | epidemiology | Pyrimidines | Heart Failure | Hydroxymethylglutaryl-CoA Reductase Inhibitors | MEDICAL AND HEALTH SCIENCES | drug therapy | complications | Fluorobenzenes | Hospitalization | etiology | statistics & numerical data | Sulfonamides | mortality | adverse effects | therapeutic use
Journal Article
The New England Journal of Medicine, ISSN 0028-4793, 07/2017, Volume 377, Issue 1, pp. 41 - 51
Journal Article
American Heart Journal, ISSN 0002-8703, 2010, Volume 159, Issue 3, pp. 331 - 339
Atrial fibrillation (AF) is associated with increased risk of stroke that can be attenuated with vitamin K antagonists (VKAs). Vitamin K antagonist use is... 
Cardiovascular | XIMELAGATRAN | CARDIAC & CARDIOVASCULAR SYSTEMS | ANTICOAGULATION CONTROL | WARFARIN | ANTITHROMBOTIC THERAPY | PREVENTION | RISK | HEPARIN | ASPIRIN | FACTOR XA INHIBITOR | ANTIPLATELET THERAPY | Pyrazoles - therapeutic use | Factor Xa Inhibitors | Follow-Up Studies | Humans | Middle Aged | Warfarin - adverse effects | Warfarin - therapeutic use | Young Adult | Fibrinolytic Agents - adverse effects | Thromboembolism - prevention & control | Fibrinolytic Agents - therapeutic use | Adult | Pyrazoles - adverse effects | Stroke - prevention & control | Atrial Fibrillation - drug therapy | Anticoagulants - therapeutic use | Treatment Outcome | Anticoagulants - adverse effects | International Normalized Ratio | Adolescent | Aged | Pyridones - therapeutic use | Hemorrhage - chemically induced | Research Design | Pyridones - adverse effects | Stroke (Disease) | Clinical trials | Medical colleges | Warfarin | Atrial fibrillation | Risk factors | Health care | Anticoagulants | Cardiac arrhythmia | Stroke | Mortality | Thrombosis | Joint replacement surgery | Disease prevention | Blood platelets | Biomarkers | Blood pressure | Diabetes | Drug therapy | Drug dosages | Index Medicus | Abridged Index Medicus | Pyrazoles | Pyridones | Factor Xa | Fibrinolytic Agents | Hemorrhage | Life Sciences | Thromboembolism | Atrial Fibrillation | Medical and Health Sciences | MEDICINE | Medicin och hälsovetenskap | MEDICIN
Journal Article
Journal Article